Information for Authors
Manuscripts for submission to Investigative and Clinical Urology (Investig Clin Urol, ICUrology) should be prepared according to the following instructions. To maintain rapid peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
GENERAL INFORMATION
Investigative and Clinical Urology is an international, peer-reviewed, open access journal covering clinical and basic science relevant to physicians and researchers in the field of urology. The official abbreviated journal name is Investig Clin Urol. The journal is published bimonthly on 10th of January, March, May, July, September, and November, and supplementary issues are published if it is needed.
Material submitted for publication should be the result of a recent investigation, should be scientifically sound, and should be theoretically well organized. Manuscripts are considered for publication with the understanding that they have not been published previously and are not under consideration by another journal. ICUrology follows Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals available from http://www.icmje.org/recommendations/ and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA) available from http://doaj.org/bestpractice if not described otherwise below.
SUBMISSION
Submission to ICUrology proceeds totally online via the web submission system for this journal, https://mc04.manuscriptcentral.com/icurology. You will be guided stepwise through the creation and uploading of the various files. You will need to provide an electronic version of your manuscript and a separate electronic version of the abstract. You must select a category for your manuscript (see below). Once the uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the editor's decision and request for revisions, will be done by e-mail.
RESEARCH AND PUBLICATION ETHICS
This statement aims to provide guidelines about the responsibilities of authors who submit papers to ICUrology. This statement also helps reviewers and editors to prevent any malpractice associated with the publication of papers. This statement covers all papers, including review articles, original articles, innovations in urology, letters to editors, and any other publication types submitted to ICUrology.
1. Research Ethics
All manuscripts should be prepared in strict observation of the research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), World Association of Medical Editors (WAME, http://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/en/main_en). Any study including human subjects or human data must be reviewed and approved by a responsible institutional review board (IRB).
Please refer to the principles embodied in the Declaration of Helsinki (2013; https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee. The editor of ICUrology may request submission of copies of informed consent from human subjects in clinical studies or IRB approval documents.
A clinical trial defined as "any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome" should be registered to the primary registry prior to publication. ICUrology accepts registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (http://www.who.int/ictrp/en/), NIH ClinicalTrials.gov (http://www.clinicaltrials.gov/), ISRCTN Register (http://www.isrctn.com/), University Hospital Medical Information Network (http://www.umin.ac.jp/ctr/index/htm/), or Clinical Research Information Service (http://cris.nih.go.kr). The clinical trial registration number shall be published at the end of the abstract. Authors should consult and follow the relevant guidelines for reporting health research data, such as the CONSORT guidelines (http://www.consort-statement.org/) for randomized, controlled trials and the PRISMA statement (http://www.prisma-statement.org/) for Systematic Reviews and Meta-Analyses.
2. Disclosure of Conflicts of Interest
A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the Acknowledgments section within the manuscript.
The Author Submission Requirement Form should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript and can be found on https://www.icurology.org/src/ICU-Author_Submission_Requirement_Form.pdf .
3. Authorship and Author's Responsibilities
The ICUrology requires that all authors complete an authorship form (download form at https://www.icurology.org/index.php?body=instruction) in their cover letter. The ICUrology follows the recommendations for authorship by the ICMJE, 2019 (http://www.icmje.org/icmje-recommendations.pdf). Author credit should be based on (1) substantial contributions to the conception and design, or acquisition, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to preserve the status of authorship for those who deserve credit and can take responsibility for the work.
Group authorship should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship and should complete an authorship form. The corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name .
4. Publication Ethics
Manuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium. Copies of related or possibly duplicative materials (i.e., those containing substantially similar content or using the same or similar data) that have been previously published or are under consideration elsewhere must be provided at the time of manuscript submission.
The editorial board should monitor and guard publication ethics about all papers submitted to ICUrology. All manuscripts submitted to the ICUrology may be screened, using the iThenticate tool (Similarity Check), for textual similarity to other previously published works. The Editorial Board of ICUrology will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check. When malpractices are found in the submitted article to ICUrology, ICUrology will follow the flowchart by the Committee on Publication Ethics (COPE, http://publicationethics.org/resources/flowcharts) for settlement of any misconduct. The editorial board of ICUrology is always willing to publish corrections, clarifications, retractions when needed.
ARTICLE CATEGORIES
The article types include original articles, review articles, special articles, innovations in urology, editorials, and letters to the editor.
Topics include precision medicine in urology, urological oncology, robotics/laparoscopy, endourology/urolithiasis, lower urinary tract dysfunction, female urology, sexual dysfunction/infertility, infection/inflammation, reconstruction/transplantation, geriatric urology, pediatric urology, and basic/translational research.
Special features include easy-to-access online video clips and illustrations of newly developed surgical techniques that can be accessed on the journal's website (https://icurology.org) or by a QR (quick response) code located in the article.
……
更多详情：
https://www.icurology.org/index.php?body=instruction
